Table 1 Dataset content from PrognoScan
From: PrognoScan: a new database for meta-analysis of the prognostic value of genes
Dataset | Cancer type | Subtype | Cohort | Author/Contributor | Array type | n | Data source |
|---|---|---|---|---|---|---|---|
GSE13507 | Bladder cancer | Transitional cell carcinoma | Cheongju | Kim | Human-6 v2 | n = 165 | GEO |
GSE5287 | Bladder cancer |  | Aarhus (1995–2004) | Als et al. [10] | HG-U133A | n = 30 | GEO |
GSE12417-GPL570 | Blood cancer | AML | AMLCG (2004) | Metzeler et al. [11] | HG-U133_Plus_2 | n = 79 | GEO |
GSE12417-GPL96 | Blood cancer | AML | AMLCG (1999–2003) | Metzeler et al. [11] | HG-U133A | n = 163 | GEO |
GSE12417-GPL97 | Blood cancer | AML | AMLCG (1999–2003) | Metzeler et al. [11] | HG-U133B | n = 163 | GEO |
GSE8970 | Blood cancer | AML | San Diego | Raponi et al. [12] | HG-U133A | n = 34 | GEO |
GSE4475 | Blood cancer | B-cell lymphoma | Berlin (2003–2005) | Hummel et al. [13] | HG-U133A | n = 158 | GEO |
E-TABM-346 | Blood cancer | DLBCL | GELA (1998–2000) | Jais et al. [14] | HG-U133A | n = 53 | ArrayExpress |
GSE2658 | Blood cancer | Multiple myeloma | Arkansas | Zhan et al. [15] | HG-U133_Plus_2 | n = 559 | GEO |
E-TABM-158 | Breast cancer |  | UCSF, CPMC (1989–1997) | Chin et al. [16] | HG-U133A | n = 129 | ArrayExpress |
GSE11121 | Breast cancer |  | Mainz (1988–1998) | Schmidt et al. [17] | HG-U133A | n = 200 | GEO |
GSE1378 | Breast cancer |  | MGH (1987–2000) | Ma et al. [18] | Arcturus 22 k | n = 60 | GEO |
GSE1379 | Breast cancer |  | MGH (1987–2000) | Ma et al. [18] | Arcturus 22 k | n = 60 | GEO |
GSE1456-GPL96 | Breast cancer |  | Stockholm (1994–1996) | Pawitan et al. [19] | HG-U133A | n = 159 | GEO |
GSE1456-GPL97 | Breast cancer |  | Stockholm (1994–1996) | Pawitan et al. [19] | HG-U133B | n = 159 | GEO |
GSE2034 | Breast cancer |  | Rotterdam (1980–1995) | Wang et al. [20] | HG-U133A | n = 286 | GEO |
GSE2990 | Breast cancer | Â | Uppsala, Oxford | Sotiriou et al. [21] | HG-U133A | n = 187 | GEO |
GSE3143 | Breast cancer | Â | Duke | Bild et al. [22] | HG-U95A | n = 158 | GEO |
GSE3494-GPL96 | Breast cancer |  | Uppsala (1987–1989) | Miller et al. [23] | HG-U133A | n = 236 | GEO |
GSE3494-GPL97 | Breast cancer |  | Uppsala (1987–1989) | Miller et al. [23] | HG-U133B | n = 236 | GEO |
GSE4922-GPL96 | Breast cancer |  | Uppsala (1987–1989) | Ivshina et al. [24] | HG-U133A | n = 249 | GEO |
GSE4922-GPL97 | Breast cancer |  | Uppsala (1987–1989) | Ivshina et al. [24] | HG-U133B | n = 249 | GEO |
GSE6532-GPL570 | Breast cancer | Â | GUYT | Loi et al. [25] | HG-U133_Plus_2 | n = 87 | GEO |
GSE7378 | Breast cancer | Â | UCSF | Zhou et al. [26] | U133AAofAv2 | n = 54 | GEO |
GSE7390 | Breast cancer |  | Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980–1998) | Desmedt et al. [27] | HG-U133A | n = 198 | GEO |
GSE7849 | Breast cancer |  | Duke (1990–2001) | Anders et al. [28] | HG-U95A | n = 76 | GEO |
GSE9195 | Breast cancer | Â | GUYT2 | Loi et al. [25] | HG-U133_Plus_2 | n = 77 | GEO |
GSE9893 | Breast cancer |  | Montpellier, Bordeaux, Turin (1989–2001) | Chanrion et al. [29] | MLRG Human 21 K V12.0 | n = 155 | GEO |
GSE11595 | Esophagus cancer | Adenocarcinoma | Sutton | Giddings | CRUKDMF_22 K_v1.0.0 | n = 34 | GEO |
GSE7696 | Glioma | Glioblastoma | Lausanne | Murat et al. [30] | HG-U133_Plus_2 | n = 70 | GEO |
GSE4271-GPL96 | Glioma | Â | MDA | Phillips et al. [31] | HG-U133A | n = 77 | GEO |
GSE4271-GPL97 | Glioma | Â | MDA | Phillips et al. [31] | HG-U133B | n = 77 | GEO |
GSE2837 | Head and neck cancer | Squamous cell carcinoma | VUMC, VAMC, UTMDACC (1992–2005) | Chung et al. [32] | U133_X3P | n = 28 | GEO |
HARVARD-LC | Lung cancer | Adenocarcinoma | Harvard | Beer et al. [33] | HG-U95A | n = 84 | Author's web site |
MICHIGAN-LC | Lung cancer | Adenocarcinoma | Michigan (1994–2000) | Beer et al. [33] | HuGeneFL | n = 86 | Author's web site |
GSE11117 | Lung cancer | NSCLC | Basel | Baty | Novachip human 34.5 k | n = 41 | GEO |
GSE3141 | Lung cancer | NSCLC | Duke | Bild et al. [22] | HG-U133_Plus_2 | n = 111 | GEO |
GSE4716-GPL3694 | Lung cancer | NSCLC | Nagoya (1995–1996) | Tomida et al. [34] | GF200 | n = 50 | GEO |
GSE4716-GPL3696 | Lung cancer | NSCLC | Nagoya (1995–1996) | Tomida et al. [34] | GF201 | n = 50 | GEO |
GSE8894 | Lung cancer | NSCLC | Seoul | Son | HG-U133_Plus_2 | n = 138 | GEO |
GSE4573 | Lung cancer | Squamous cell carcinoma | Michigan (1991–2002) | Raponi et al. [35] | HG-U133A | n = 129 | GEO |
DUKE-OC | Ovarian cancer | Â | Duke | Bild et al. [22] | HG-U133A | n = 134 | Author's web site |
GSE8841 | Ovarian cancer | Â | Milan | Mariani | G4100A | n = 83 | GEO |
E-DKFZ-1 | Renal cell carcinoma | Â | RZPD | Sueltmann | A-RZPD-20 | n = 74 | ArrayExpress |